0001104659-21-128007.txt : 20211020 0001104659-21-128007.hdr.sgml : 20211020 20211020140657 ACCESSION NUMBER: 0001104659-21-128007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211020 DATE AS OF CHANGE: 20211020 EFFECTIVENESS DATE: 20211020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Plato BioPharma, Inc. CENTRAL INDEX KEY: 0001494188 IRS NUMBER: 271519734 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-417748 FILM NUMBER: 211333723 BUSINESS ADDRESS: STREET 1: 7581 W. 103RD AVE. SUITE 300 CITY: WESTMINSTER STATE: CO ZIP: 80021 BUSINESS PHONE: 720-887-8628 MAIL ADDRESS: STREET 1: 7581 W. 103RD AVE. SUITE 300 CITY: WESTMINSTER STATE: CO ZIP: 80021 D 1 primary_doc.xml X0708 D LIVE 0001494188 Plato BioPharma, Inc. 2701 KENT AVE WEST LAFAYETTE IN INDIANA 47906-1382 3174634527 DELAWARE None None Corporation true Robert Leasure, Jr. 2701 Kent Ave West Lafayette IN INDIANA 47906-1382 Executive Officer Director Beth A. Taylor 2701 Kent Ave West Lafayette IN INDIANA 47906-1382 Executive Officer Director Other Health Care Decline to Disclose 06b false 2021-10-04 false true true 0 3000000 3000000 0 false 39 0 0 0 The securities were issued as consideration in an acquisition. false Plato BioPharma, Inc. /s/ Beth A. Taylor Beth A. Taylor CFO Vice President Finance 2021-10-20